Cargando…
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467342/ https://www.ncbi.nlm.nih.gov/pubmed/31360089 http://dx.doi.org/10.2147/BLCTT.S169529 |
| _version_ | 1783411252811268096 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6467342 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64673422019-07-29 Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum] Blood Lymphat Cancer Erratum Dove Medical Press 2018-04-18 /pmc/articles/PMC6467342/ /pubmed/31360089 http://dx.doi.org/10.2147/BLCTT.S169529 Text en © 2018 Anagnostou and Litzow. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Erratum Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum] |
| title | Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum] |
| title_full | Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum] |
| title_fullStr | Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum] |
| title_full_unstemmed | Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum] |
| title_short | Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum] |
| title_sort | spotlight on ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [erratum] |
| topic | Erratum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467342/ https://www.ncbi.nlm.nih.gov/pubmed/31360089 http://dx.doi.org/10.2147/BLCTT.S169529 |